|
Market Closed -
Toronto S.E.
15:57:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 36.94 CAD | +1.43% |
|
+5.57% | +14.01% |
| 08-21 | AbbVie Presents New Data Across Lung Cancer Pipeline At WCLC 2026 | CI |
| 08-20 | Piper Sandler Adjusts Price Target on AbbVie to $303 From $298, Maintains Overweight Rating | MT |
Chart: Technical Analysis
Stock exchange
Toronto S.E.
ABBV 36.94 $
+1.43%
63.72K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| ABBV | 264.96USD | +1.20% | 1.37B $ | |
CBOE
| ABBV | 265.11USD | +1.28% | 31.41M $ | |
Tradegate
| 4AB | 226.90EUR | +1.16% | 989K € | |
London S.E.
| 0QCV | 266.00USD | +0.76% | 103K $ | |
Boerse Muenchen
| 4AB | 226.55EUR | +0.89% | 72.04K € | |
Xetra
| 4AB | 228.10EUR | +0.35% | 55.66K € | |
CBOE
| 227.50EUR | +0.44% | 30.48K € | ||
CBOE
| 0QCV | 225.90EUR | -0.18% | 13.55K € | |
Borsa Italiana
| 1ABBV | 227.00EUR | +0.44% | 11.8K € | |
Börse Stuttgart
| 4AB | 227.00EUR | +1.25% | 10.22K € | |
Deutsche Boerse AG
| 4AB | 226.90EUR | +0.84% | 9.76K € | |
Mexican S.E.
| ABBV * | 4,495.00MXN | -0.24% | 94.4K $ | |
Swiss Exchange
| ABBV | 212.30CHF | +0.40% | 0 CHF | |
Wiener Boerse
| ABBV | 227.80EUR | +0.26% | 0 € | |
Santiago S.E.
| ABBV | 250.33USD | 0.00% | 0 $ | |
Santiago S.E.
| ABBVCL | 228,850.00CLP | 0.00% | 0 $ | |
Swiss Exchange
| ABBV | 264.85USD | +0.06% | 0 $ | |
Buenos Aires S.E.
| ABBVD | 27.70USD | +2.71% | 1.66K $ | |
Buenos Aires S.E.
| ABBV | 42,260.00ARS | +1.88% | 47.29M $ | |
Toronto S.E.
| ABBV | 36.94CAD | +1.43% | 63.72K $ | |
Deutsche Boerse AG
| 4AB0 | 24.20EUR | +14.15% | 96.8 € | |
Thailand S.E.
| ABBV19 | 8.600THB | -1.71% | 533K ฿ | |
Thailand S.E.
| ABBV80 | 8.600THB | -1.71% | 419K ฿ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABBV Stock
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions

















